Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 1/20 | 0.55 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.55 |
| ▸ | FBP1 | P09467 | 3/20 | 0.54 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.53 |
| ▸ | P4HB | P07237 | 9/20 | 0.48 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.45 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9475845 | 0.92 | PDCD1 (0.51) | PDCD1CD274FBP1GLO1P4HB | |
| SCHEMBL9475839 | 0.92 | PDCD1 (0.51) | PDCD1CD274FBP1GLO1P4HB | |
| SCHEMBL6947909 | 0.88 | PDCD1 (0.54) | PDCD1CD274FBP1GLO1P4HB | |
| SCHEMBL6947906 | 0.88 | PDCD1 (0.54) | PDCD1CD274FBP1GLO1P4HB | |
| SCHEMBL10375509 | 0.85 | PDCD1 (0.71) | PDCD1CD274FBP1GLO1KDM4E | |
| SCHEMBL10848993 | 0.85 | PDCD1 (0.71) | PDCD1CD274FBP1GLO1KDM4E | |
| SCHEMBL8028834 | 0.84 | PDCD1 (0.59) | PDCD1CD274FBP1P4HBGRIN2D | |
| SCHEMBL6981746 | 0.83 | AKR1C3 (0.59) | PDCD1CD274FBP1P4HBMAOA | |
| SCHEMBL3115027 | 0.83 | AKR1C3 (0.59) | PDCD1CD274FBP1P4HBMAOA | |
| SCHEMBL28372992 | 0.83 | AKR1C3 (0.59) | PDCD1CD274FBP1P4HBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-20060024365-A1 | Novel dosage form | VAYA NAVIN | 2006-02-02 | — | — | US | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| CN-1230891-A | Lectin compositions and uses thereof | ALIZYME THERAPEUTICS LTD (GB) | 1999-10-06 | — | — | CN | claimed |
| US-5962024-A | DRUG RELEASE CONTROLLING AGENT CONSISTS SUBSTANTIALLY OF A PH-SENSITIVE ENTERIC POLYMER. | ORION-YHTYMA OY (FI) | 1999-10-05 | — | — | US | claimed |
| EP-0942741-A1 | LECTIN COMPOSITIONS AND USES THEREOF | Alizyme Therapeutics Limited (GB) | 1999-09-22 | — | — | EP | claimed |
| WO-1997049420-A1 | LECTIN COMPOSITIONS AND USES THEREOF | ALIZYME THERAPEUTICS LIMITED (GB) | 1997-12-31 | — | — | WO | claimed |
| EP-0357403-B1 | Substituted beta-diketones | ORION YHTYMAE OY (FI) | 1994-12-14 | — | — | EP | claimed |
| US-5292771-A | Treating inflammatory bowel disease | ORION-YHTYMA OY (FI) | 1994-03-08 | — | — | US | claimed |
| US-5288750-A | Antiulcer agents for gastrointestinal disorders | ORION-YHTYMA OY (FI) | 1994-02-22 | — | — | US | claimed |
| EP-0440324-A2 | Substituted beta-diketones and their use | ORION-YHTYMÀ OY (FI) | 1991-08-07 | — | — | EP | claimed |
| WO-1990002724-A1 | SUBSTITUTED β-DIKETONES | Orion-Yhtymä Oy (FI) | 1990-03-22 | — | — | WO | claimed |
| EP-0357403-A2 | Substituted beta-diketones | ORION-YHTYMÀ OY (FI) | 1990-03-07 | — | — | EP | claimed |